kr530.00
1.85%
Stockholm, Sep 24, 05:29 pm CEST. Closed.
ISIN
SE0009160872
Symbol
MCAP

MedCap AB Target price 2026 - Analyst rating & recommendation

MedCap AB Classifications & Recommendation

Buy
86%
Hold
14%

MedCap AB Price Target

Target Price kr652.80
Price kr530.00
Potential
Number of Estimates 4
4 Analysts have issued a price target MedCap AB 2027 . The average MedCap AB target price is kr652.80. This is higher than the current stock price. The highest price target is , the lowest is .
A rating was issued by 7 analysts: 6 Analysts recommend MedCap AB to buy, 1 to hold and 0 to sell.
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
Analyst Estimates: Analysts believe that the MedCap AB stock has an average upside potential 2027 of . Most analysts recommend the MedCap AB stock at Purchase.

Sales and Margin forecast 2026, 2027 & 2028

Create a premium account to unlock analyst estimates. Learn more

Select at least one metric to display the chart.


Quarter Annually
Dec '25 2026
Estimates
Revenue Billion kr 2.11 2.43
16.68% 15.13%
EBITDA Margin 21.64% 22.78%
0.85% 5.26%
Net Margin 10.43% 10.86%
9.17% 4.15%

4 Analysts have issued a sales forecast MedCap AB 2026 . The average MedCap AB sales estimate is

kr2.4b
unlock
. This is
7.61% higher
unlock
than the revenue of the last 12 months(TTM). The highest sales forecast is
kr2.5b 12.71%
unlock
, the lowest is
kr2.3b 1.58%
unlock
.

This results in the following potential growth metrics:

Revenue Estimates

2025 kr2.1b 16.68%
2026
kr2.4b 15.13%
unlock
2027
kr2.7b 11.62%
unlock
2028
kr3.0b 8.97%
unlock

4 Analysts have issued an MedCap AB EBITDA forecast 2026. The average MedCap AB EBITDA estimate is

kr553m
unlock
. This is
5.95% higher
unlock
than the EBITDA of the last 12 months(TTM). The highest EBITDA forecast is
kr582m 11.48%
unlock
, the lowest is
kr519m 0.46%
unlock
.

This results in the following potential growth metrics and future EBITDA Margins:

EBITDA Estimates

2025 kr456m 17.67%
2026
kr553m 21.18%
unlock
2027
kr638m 15.41%
unlock
2028
kr701m 9.91%
unlock

EBITDA Margin

2025 21.64% 0.85%
2026
22.78% 5.26%
unlock
2027
23.55% 3.38%
unlock
2028
23.76% 0.89%
unlock

3 MedCap AB Analysts have issued a net profit forecast 2026. The average MedCap AB net profit estimate is

kr264m
unlock
. This is
9.50% higher
unlock
than the net profit for the last 12 months(TTM). The highest net profit forecast is
kr271m 12.73%
unlock
, the lowest is
kr253m 5.21%
unlock
.

This results in the following potential growth metrics and future Net Margins:

Net Profit Estimates

2025 kr220m 5.98%
2026
kr264m 19.91%
unlock
2027
kr311m 18.09%
unlock
2028
kr347m 11.49%
unlock

Net Margin

2025 10.43% 9.17%
2026
10.86% 4.15%
unlock
2027
11.49% 5.80%
unlock
2028
11.75% 2.26%
unlock

Earnings per share, P/E ratio and EV/sales Estimates 2026, 2027 & 2028

Create a premium account to unlock analyst estimates. Learn more

Select at least one metric to display the chart.


Quarter Annually
Dec '25 2026
Estimates
Earnings Per Share kr 14.65 17.60
4.72% 20.14%
P/E 30.69
EV/Sales 3.42

3 Analysts have issued a MedCap AB forecast for earnings per share. The average MedCap AB EPS is

kr17.60
unlock
. This is
9.52% higher
unlock
than earnings per share in the financial year 2025. The highest EPS forecast is
kr18.11 12.69%
unlock
, the lowest is
kr16.91 5.23%
unlock
.

This results in the following potential growth metrics and future valuations:

Earnings Per Share

2025 kr14.65 4.72%
2026
kr17.60 20.14%
unlock
2027
kr20.78 18.07%
unlock
2028
kr23.16 11.45%
unlock

P/E ratio

Current 33.60 26.87%
2026
30.69 8.67%
unlock
2027
25.99 15.31%
unlock
2028
23.31 10.31%
unlock

Based on analysts' sales estimates for 2026, the MedCap AB stock is valued at an EV/Sales of

and an P/S ratio of .

This results in the following potential growth metrics and future valuations:

EV/Sales

Current 3.68 23.81%
2026
3.42 7.07%
unlock
2027
3.06 10.41%
unlock
2028
2.81 8.23%
unlock

P/S ratio

Current 3.60 25.33%
2026
3.35 7.07%
unlock
2027
3.00 10.41%
unlock
2028
2.75 8.23%
unlock

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today